| answer text |
<p>The Department is doing everything appropriate to prepare for the United Kingdom’s
exit from the European Union. Our plans should ensure the supply of medicines and
medical products when we leave the EU on 31 October.</p><p>The Department, in consultation
with the devolved administrations, has been working with trade bodies, product suppliers,
and the health and care system in England to make detailed plans that should ensure
continuation of the supply of medical products to the whole of the UK and its Crown
Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the
UK from or via the EU or European Economic Area setting out our continuing multi-layered
approach to support continuity of supply of medicines and medical products from 31
October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans"
target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>As
with our plans leading up to 29<sup> </sup>March, for those medicines that cannot
be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes
for use in the diagnosis and treatment of cancer, we have asked suppliers to make
alternative arrangements, using air freight, which some suppliers are already doing
now. We have offered support to companies to arrange this.</p><p> </p>
|
|
